Photodynamic therapy for metastatic breast cancer
Abstract
Results of treatment for cutaneous metastasis of breast cancer with photjdynamic therapy are represented. The study included 46 patients, the total number of treated cutaneous metastases was 535. For photodynamic therapy photosensitizer photolon given intravenously at a dose of 0.9–1.6 mg/kg body weight 3 h before treatment session (wave length 661±1 nm, плотность мощности 0,11–0,56 J/cm2), мощность на выходе волокна 0,3–2,0 Wt, light dose 50–600 J/cm2. Complete regression of metastasis was obtained in 33.6% of cases, partial – in 39.4%, stabilization – in 22.6%, progression of disease was in 4.3% of cases. The results show the perspectiveness of photodynamic therapy for metastasis as one of the step of treatment.
About the Authors
E. V. HoranskayaRussian Federation
M. A. Kaplan
Russian Federation
V. N. Kapinous
Russian Federation
E. V. Yaroslavtseva
Russian Federation
I. S. Spichenkova
Russian Federation
A. M. Shubina
Russian Federation
O. V. Borgul
Russian Federation
Ju. A. Ragulin
Russian Federation
M. V. Taibova
Russian Federation
References
1. Чиссов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2010 году. М.: ФГУ «МНИОИ им П.А. Герцена» Минздравсоцразвития России, 2011. – 188 с.
2. Reynolds T. Photodynamic Therapy Expands Its Horizons // JNCI J Natl Cancer Inst. – 1997. –Vol. 89, № 2. – P. 112–114.
3. Huinink W. ten Bokkel Treatment of skin metastases of breast cancer // Cancer Chemother. Pharmacol. – 1999. – №44. – P.31–33.
4. Clive S., Gardiner J., Leonard R.S.F. Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma // Cancer Chemother Pharmacol. – 1999. – № 44. – P. 29–30.
5. Gehl J., Matthiessen L.M., Humphreys A. Management of cutaneous metastases by electrochemotherapy // J. Clin. Oncol. – 2010. – № 28. – P. 15.
6. Странадко Е. Ф. Механизмы действия фотодинамической терапии // Российский онкологический журнал. – 2008. – Т. 4, №4. – С. 52.
7. Dougherty T. J. An update on photodynamic therapy applications // J Clin Laser Med Surg. – 2002. – Vol. 20, №1. – P. 3–7.
8. Huang Z., Xu H., Meyers A. D. et al. Photodynamic therapy for treatment of solid tumors-potential and technical challenges // Technol. Cancer Res. Treat. – 2008. – Vol.7, №4. P. 309–320.
9. Anderson C., Hrabovsky S., McKinley Y. et al. Phthalocyanine photodynamic therapy disparate effects of pharmacological ingibitors on cutaneous photosensitivity and on tumour regression // J. Photochem. Photobiol. – 1997. – Vol. 65, № 5. – P. 895–901.
10. Castano A. P., Mroz P., Hamblin M. R. Photodynamik therapy and antitumour immunity // Nature Reviews Canser. – 2006. – №6. – P. 535–545.
11. Cuenca R. E., Allison R. R., Sibata C. et al. Breast Cancer With Chest Wall Progression: Treatment With Photodynamic Therapy// Annals of Sugical Oncology. – 2004. – Vol.11, №3. – P. 322–327.
12. Wyss P., Schwarz V., Dobler-Girdziunaite D. et al. Photodynamik therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer // Int. J. Cancer. – 2001. – № 93. – P. 720–724.
Review
For citations:
Horanskaya E.V., Kaplan M.A., Kapinous V.N., Yaroslavtseva E.V., Spichenkova I.S., Shubina A.M., Borgul O.V., Ragulin J.A., Taibova M.V. Photodynamic therapy for metastatic breast cancer. Photodynamic therapy and photodyagnosis. 2014;3(2):15-17. (In Russ.)